Literature DB >> 34132470

Evidence of an untamed HIV epidemic among MSM and TGW in Rio de Janeiro, Brazil: a 2018 to 2020 cross-sectional study using recent infection testing.

Sylvia Lm Teixeira1, Cristina M Jalil2, Emilia M Jalil2, Sandro C Nazer2, Simone da Costa Cruz Silva2, Valdilea G Veloso2, Paula M Luz2, Beatriz Grinsztejn2.   

Abstract

INTRODUCTION: Monitoring the HIV epidemic and identifying populations among whom HIV is spreading is critical. We aimed to provide an estimate of the annualized HIV incidence rate using recency testing among cisgender men who have sex with men (MSM) and transgender women (TGW) at a reference centre in Rio de Janeiro, Brazil.
METHODS: We evaluated MSM and TGW who sought HIV testing at the Evandro Chagas National Institute of Infectious Diseases-FIOCRUZ between March 2018 and January 2020. The Limiting Avidity assay (LAg) as part of a recent infection testing algorithm (RITA) was employed to identify recent infections (those with a normalized optical density ≤1.5 in the LAg that met all RITA criteria) among those who tested positive for HIV and the annualized HIV incidence was estimated. RESULTS AND DISCUSSION: Out of 3053 individuals assessed, 2591 (84.9%) were HIV negative and 462 (15.1%) were living with HIV. Among these, 302 (65.4%) with stored samples available were evaluated and 73/302 (24.2%) were classified as recent infections. The annualized incidence rate estimate using a false recency rate of zero was 7.35% (95% CI 5.76% to 9.25%).
CONCLUSIONS: Our results suggest that the HIV epidemic in Rio de Janeiro, Brazil, continues to disproportionately burden vulnerable populations, including MSM and TGW despite the existence and availability of effective preventive and therapeutic interventions.
© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Entities:  

Keywords:  HIV; MSM; diagnosis; incidence; recency; trans women

Year:  2021        PMID: 34132470     DOI: 10.1002/jia2.25743

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN: 1758-2652            Impact factor:   5.396


  3 in total

1.  High Rates of Sexualized Drug Use or Chemsex among Brazilian Transgender Women and Young Sexual and Gender Minorities.

Authors:  Emilia M Jalil; Thiago S Torres; Claudia C de A Pereira; Alessandro Farias; Jose D U Brito; Marcus Lacerda; Daila A R da Silva; Nickols Wallys; Gabriela Ribeiro; Joyce Gomes; Thiffany Odara; Ludymilla Santiago; Sophie Nouveau; Marcos Benedetti; Cristina Pimenta; Brenda Hoagland; Beatriz Grinsztejn; Valdilea G Veloso
Journal:  Int J Environ Res Public Health       Date:  2022-02-02       Impact factor: 3.390

2.  Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug-drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis.

Authors:  Vitória Berg Cattani; Emilia Moreira Jalil; Leonardo Eksterman; Thiago Torres; Sandra Wagner Cardoso; Cristiane R V Castro; Laylla Monteiro; Erin Wilson; Lane Bushman; Peter Anderson; Valdilea Gonçalves Veloso; Beatriz Grinsztejn; Rita Estrela
Journal:  J Antimicrob Chemother       Date:  2022-09-30       Impact factor: 5.758

Review 3.  Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.

Authors:  Shelley N Facente; Eduard Grebe; Andrew D Maher; Douglas Fox; Susan Scheer; Mary Mahy; Shona Dalal; David Lowrance; Kimberly Marsh
Journal:  JMIR Public Health Surveill       Date:  2022-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.